Weight loss : In astudyof 175 participants with overweight or obesity, those taking semaglutide lost 5.9% of their body weight at 3 months and 10.9% at 6 months
Although research remains at the preclinical animal stage, the product has become an important tool for dissecting glucose metabolism disorders and diabetes and developing novel hypoglycemic agents, with its key advantage lying in nicotinamide pathway regulation and NAD+ stabilization
Chen QY, Wang GG, Li W, Jiang YX, Lu XH, Zhou PP
Aerobic exercise like walking, running, swimming, dancing, cycling, and more helps protect cardiovascular health and insulin sensitivity
Additional mechanistic studies will however be necessary to fully understand the molecular action of tirzepatide